RAUL SOTO-ACOSTA: Open Payments
NPI 1619991106 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,249 in 10 payments from 6 companies in 2025. Trend: 2023 $94 · 2024 $349 · 2025 $25,249
Debt forgiveness: $25,025Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $25,025 |
| Lundbeck LLC | 3 | $74 |
| Alkermes, Inc. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, REXULTI, ARISTADA, TRINTELLIX, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across FL — which companies pay providers there.
